Some U.S. drugmakers still see benefit of being in vaccine business

10/29/2004 | NYTimes.com

Despite recent shortages of flu vaccine, some pharmaceutical manufacturers believe making vaccines is still a good business. Several U.S. drugmakers are actively developing new vaccines for diseases ranging from infections obtained in kidney dialysis centers to viruses that cause ebola, West Nile and SARS to pneumococcal-caused diseases.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI